查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
居家睡眠呼吸中止设备市场：2023年至2028年预测
市场调查报告书
商品编码
1410139

居家睡眠呼吸中止设备市场：2023年至2028年预测

Home-Based Sleep Apnea Devices Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

家庭睡眠呼吸中止设备市场预计将从2021年的15.56亿美元成长到2028年的45.23亿美元，复合年增长率为16.47%。

近年来，由于睡眠呼吸中止症的盛行率不断增加以及人们对其潜在健康危害的认识不断增强，家庭睡眠呼吸中止设备市场显着增长。这些最尖端科技提供了一种简单、非侵入性的方法，让您可以在舒适的家中监测和诊断睡眠呼吸中止。透过利用气流感测器、脉搏血氧计和穿戴式装置等创新技术，这些家用系统可以正确检测睡眠障碍，并向医疗保健专业人员提供关键资料。对远端患者监测和远端医疗的日益重视正在推动对此类设备的需求，为睡眠呼吸中止护理提供具有成本效益且易于使用的选择。随着全球人口寻求更好的睡眠，家庭睡眠呼吸中止设备市场预计将在未来几年稳步扩大。

睡眠呼吸中止症盛行率的上升正在推动家庭睡眠呼吸中止设备市场的成长。

睡眠呼吸中止症盛行率的增加是家庭睡眠呼吸中止设备市场的主要成长要素。世界上很大一部分人口患有睡眠呼吸中止，这是一种以睡眠期间呼吸问题为特征的睡眠障碍。生活方式的改变、肥胖、人口老化以及人们对睡眠问题的认识不断提高，导致这种疾病的盛行率不断上升。因此，对有效且方便的家用设备的需求不断增长，这些设备可以监测和诊断睡眠呼吸中止，使人们能够在舒适的家中管理自己的疾病。开拓和医疗保健提供者正在积极投资此类设备的开发和行销，以满足不断增长的患者需求，并减轻睡眠呼吸中止中止症对公共卫生系统日益严重的影响。我是。

睡眠呼吸中止设备的技术进步。

家用睡眠呼吸中止设备技术的开拓是市场扩张的主要因素。这些进步导致了更复杂和更易于使用的设备的开发，使个人更容易控制睡眠呼吸中止。先进的传感器和演算法现在可以准确、即时地监测您的睡眠模式、呼吸事件和氧气水平。此外，小型化和穿戴式技术使这些小工具更加舒适和便携，让用户安心入睡。与智慧型手机和其他智慧型装置的整合可实现平稳的资料传输和分析，为患者和医疗保健专业人员提供个人化治疗计划的宝贵见解。随着技术的进步，家庭睡眠呼吸中止设备市场预计将进一步开拓，改善患者的治疗效果并促进睡眠健康。

便利性和非侵入式监控推动了家庭睡眠呼吸中止设备的市场规模。

家用睡眠呼吸中止设备的易用性和非侵入式监测对其接受度和市场扩张发挥关键作用。与传统的实验室睡眠研究不同，这些小工具可以追踪睡眠模式和呼吸事件，同时保护个人隐私。这种非侵入性方法无需在睡眠中心住宿，从而减轻疼痛并促进改善睡眠品质。使用者可以穿戴穿戴式装置或连接非侵入式感测器，从而省去了设定标准睡眠监测设备的麻烦。将这些设备融入日常生活中可以实现连续、不引人注目的资料收集，使患者和医疗保健提供者能够评估睡眠品质、检测睡眠障碍和个人化治疗。它为规划提供了宝贵的见解，最终提高了患者的依从性和整体睡眠健康状况。

北美是家庭睡眠呼吸中止市场的市场领导者。

北美是家庭睡眠呼吸中止市场的市场领导者。这是由于许多变数造成的，包括该地区睡眠呼吸中止中止症的高盛行率、完善的医疗基础设施以及公众对睡眠障碍的认识提高。此外，技术的重大进步和有利的法规环境正在支持北美家庭睡眠呼吸中止设备的采用。重要市场参与者的存在、研发工作以及先进可穿戴技术的可用性巩固了该地区作为推动家庭睡眠呼吸中止设备市场创新和成长的先驱者的地位。

家庭睡眠呼吸中止设备市场对持续睡眠健康监测的需求。

人们越来越认识到睡眠对整体健康的重要性，这增加了对持续睡眠健康监测的需求。随着人们越来越意识到睡眠对其身心健康的影响，他们正在寻求技术来监测他们的睡眠习惯并识别潜在的睡眠问题。持续的睡眠健康监测可以持续评估睡眠品质、呼吸事件和睡眠相关指标，从而提供个人睡眠健康状况的整体情况。家用睡眠呼吸中止设备和穿戴式技术提供持续监测，使用户能够分析他们的睡眠模式、识别睡眠中断并做出明智的决定来改善他们的睡眠习惯。此外，医疗保健提供者将能够存取纵向资料，从而实现更准确的诊断、个人化治疗以及对睡眠相关疾病的主动管理，从而改善患者的治疗结果。

主要进展：

2023年6月，世界医疗技术先驱皇家飞利浦与全球医疗技术运营商Masimo宣布，飞利浦患者监护仪Intelliview MX750和MX850将配备Sedline脑功能监测、局部血氧饱和度和CO2测量功能。它已获得FDA 批准。 Masimo 和飞利浦持续合作的最新进展将帮助医生做出更快、更明智的决策，而无需额外的监测设备。 2022 年 7 月，内特斯医疗公司（Natus Medical Incorporated）是一家领先的医疗设备解决方案提供商，筛检筛检、诊断和治疗影响大脑、神经途径和八种感觉神经系统的疾病，宣布了一项专门针对医疗保健行业的重大投资。已被 ArchiMed 的 MED Platform II 基金收购。根据最终合併协议，Natus 股东每股 Natus 普通股可获得 33.50 美元现金。

公司产品

  • CPAP 机： ResMed 因其阻塞型睡眠呼吸中止症闻名。这些设备提供恆定的气流通过面罩，让您在睡眠时保持呼吸道畅通并防止呼吸中止。
  • 自动 CPAP (APAP) 机：飞利浦伟康提供的自动调节 CPAP 机可根据患者夜间的呼吸模式自动改变气压水平，确保最佳治疗和舒适度。
  • 双水平阳压呼吸器(BiPAP) 设备： Drive DeVilbiss Healthcare 推出了 BiPAP 设备，可在吸气和呼气期间提供两个独立的气压等级。该设备适合患有更复杂的睡眠呼吸中止或需要更高压力支持的人。
  • CPAP 面罩和配件BMC Medical Co., Ltd. 提供各种 CPAP 面罩，包括鼻罩、鼻枕和全面罩，以及管子、过滤器和加湿器等配件，以提高治疗过程中的舒适度和依从性。我们提供

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 资讯来源
  • 研究设计

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 业内竞争对手之间的对抗关係
  • 产业价值链分析

第五章家用睡眠呼吸中止设备市场：依设备类型

  • 介绍
  • 正压呼吸器(PAP)设备
  • 持续性阳压呼吸器(CPAP) 装置
  • 双水平阳压呼吸器(BIPAP) 装置
  • 口腔矫正器
  • 自我调整伺服通气 (ASV) 装置
  • 氧气设备
  • 其他的

第六章家用睡眠呼吸中止设备市场：依应用分类

  • 介绍
  • 手动的
  • 自动的

第 7 章 家用睡眠呼吸中止设备市场：依最终用户分类

  • 介绍
  • 医院及睡眠诊所
  • 家庭护理设置
  • 睡眠中心
  • 其他的
  • 家用睡眠呼吸中止设备市场：按地区
  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 台湾
    • 其他的

第八章竞争环境及分析

  • 主要企业及策略分析
  • 新兴企业和市场盈利
  • 合併、收购、协议和合作
  • 供应商竞争力矩阵

第九章 公司简介

  • RESMED INC.
  • KONINKLIJKE PHILIPS NV
  • FISHER & PAYKEL HEALTHCARE LIMITED
  • INVACARE CORPORATION
  • DRIVE DEVILBISS HEALTHCARE
  • BMC MEDICAL CO., LTD.
  • COMPUMEDICS LIMITED
  • NATUS MEDICAL INCORPORATED
  • NIHON KOHDEN CORPORATION
  • APEX MEDICAL CORP.
简介目录
Product Code: KSI061615809

The home-based sleep apnea devices market is expected to grow at a CAGR of 16.47% from US$1.556 billion in 2021 to US$4.523 billion in 2028.

The home-based sleep apnea devices market has grown significantly in recent years, owing to the increasing prevalence of sleep apnea and greater awareness of its potential health hazards. These cutting-edge technologies provide a simple and non-intrusive way to monitor and diagnose sleep apnea from the comfort of one's own home. These home-based systems can correctly detect sleep disorders and give vital data to healthcare experts by utilising innovative technology such as airflow sensors, pulse oximetry, and wearable gadgets. The growing emphasis on remote patient monitoring and telemedicine has spurred demand for such devices, which provide cost-effective and accessible options for sleep apnea care. As the worldwide population strives for better sleep health, the home-based sleep apnea devices market is expected to expand steadily in the coming years.

Rising Prevalence of Sleep Apnea Enhances the Home-Based Sleep Apnea Devices Market Growth.

The increased prevalence of sleep apnea is a major growth factor in the home-based sleep apnea devices market. A significant proportion of the worldwide population suffers from sleep apnea, a sleep disease characterised by disrupted breathing during sleep. Lifestyle changes, obesity, ageing demographics, and more awareness of sleep problems all contribute to the condition's rising incidence. As a result, there is a rising desire for effective and convenient home-based devices that can monitor and diagnose sleep apnea, allowing people to manage their disease from the convenience of their own homes. Manufacturers and healthcare providers are aggressively investing in developing and marketing such devices in order to meet patients' expanding requirements and alleviate the growing impact of sleep apnea on public health systems.

Technological Advancements in Home-Based Devices in Home-Based Sleep Apnea Devices Market.

Technological developments in home-based sleep apnea devices have been a major driver of market expansion. These advancements have resulted in the creation of more complex and user-friendly devices, making it easier for individuals to control their sleep apnea. Sleep patterns, respiratory events, and oxygen levels may all be monitored accurately and in real time thanks to advanced sensors and algorithms. Furthermore, miniaturisation and wearable technologies have increased the comfort and portability of these gadgets, allowing users to sleep peacefully with them. Integration with smartphones and other smart devices provides smooth data transfer and analysis, providing useful insights to patients and healthcare professionals for personalised treatment programmes. As technology advances, the home-based sleep apnea devices market is projected to see more developments, improving patient outcomes, and encouraging improved sleep health.

Convenience and Non-Intrusive Monitoring Boosts the Home-Based Sleep Apnea Devices Market Size.

The ease of use and non-intrusive monitoring provided by home-based sleep apnea devices have played an important part in their acceptance and market expansion. These gadgets, unlike traditional in-lab sleep studies, allow individuals to track their sleep patterns and respiratory episodes in the privacy of their own homes. This non-intrusive method removes the need for overnight stays in sleep centres, which reduces pain and promotes improved sleep quality. Users can easily wear wearable devices or put non-invasive sensors, eliminating the need for the time-consuming setup of standard sleep monitoring equipment. The incorporation of these devices into daily routines allows for continuous and unobtrusive data collection, providing valuable insights for both patients and healthcare providers to assess sleep quality, detect sleep disorders, and design personalised treatment plans, ultimately improving patient compliance and overall sleep health.

North America is the Market Leader in the Home-Based Sleep Apnea Devices Market.

North America was regarded as the market leader in the home-based sleep apnea devices market. This can be ascribed to a number of variables, including the region's high prevalence of sleep apnea, a well-established healthcare infrastructure, and rising public awareness of sleep disorders. Furthermore, major technology improvements and a favourable regulatory environment in North America have encouraged the introduction of home-based sleep apnea devices. The presence of significant market players, R&D efforts, and the availability of advanced wearable technologies strengthened the region's position as a trailblazer in driving innovations and growth in the home-based sleep apnea devices market.

Demand for Continuous Sleep Health Monitoring in Home-Based Sleep Apnea Devices Market.

The growing acknowledgment of the importance of sleep-in overall well-being is driving the increased need for continuous sleep health monitoring. Individuals are looking for techniques to monitor their sleep habits and identify potential sleep problems as awareness about the influence of sleep on physical and mental health grows. Continuous sleep health monitoring enables for continuous evaluation of sleep quality, respiratory events, and sleep-related indicators, offering a full picture of an individual's sleep health throughout time. Continuous monitoring is provided through home-based sleep apnea devices and wearable technology, allowing users to analyse their sleep patterns, identify sleep interruptions, and make educated decisions to improve their sleep habits. Furthermore, healthcare providers will have access to longitudinal data, which will allow for more accurate diagnosis, personalised therapy, and proactive management of sleep-related illnesses for better patient outcomes.

Key Developments:

  • In June 2023, Royal Philips, a worldwide pioneer in health technology, and Masimo, a global medical technology business, announced today that SedLine Brain Function Monitoring, Regional Oximetry, and CO2 readings in Philips Patient Monitors - IntelliVue MX750 and MX850 - have received FDA clearance. The latest development in Masimo and Philips' continuous partnership will assist physicians in making rapid and informed judgements without the need for extra monitoring equipment.
  • In July 2022, Natus Medical Incorporated, a leading provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems, announced that it had been acquired by ArchiMed's MED Platform II fund, a leading investment firm focused solely on the healthcare industry. Natus stockholders received $33.50 in cash for each share of Natus common stock, according to the official merger agreement.

Company Products:

  • CPAP Machines: ResMed is well-known for its continuous positive airway pressure (CPAP) devices, which are commonly used to treat obstructive sleep apnea (OSA). These devices provide a constant flow of air through a mask, keeping the airway open during sleep and preventing breathing pauses.
  • Auto-CPAP (APAP) Machines: Philips Respironics offered auto-adjusting CPAP devices, which automatically alter air pressure levels based on the patient's breathing patterns during the night, assuring optimal treatment and comfort.
  • Bi-Level Positive Airway Pressure (BiPAP) Machines: Drive DeVilbiss Healthcare introduced BiPAP devices, which give two separate air pressure levels during inhalation and exhalation. These devices are appropriate for people with more complicated sleep apnea disorders or requiring higher-pressure assistance.
  • CPAP Masks and Accessories: BMC Medical Co., Ltd. offers a wide range of CPAP masks, including nasal masks, nasal pillows, and full-face masks, as well as accessories like as tubing, filters, and humidifiers to improve comfort and compliance during therapy.

Segmentation:

By Type Of Device

  • Positive Airway Pressure (Pap) Devices
  • Continuous Positive Airway Pressure (Cpap) Devices
  • Bi-Level Positive Airway Pressure (Bipap) Devices
  • Oral Appliances
  • Adaptive Servo-Ventilation (Asv) Devices
  • Oxygen Devices
  • Others

By Application

  • Manual
  • Automatic

By End-User

  • Hospitals And Sleep Clinics
  • Home Care Settings
  • Sleep Centers
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Sources
  • 2.3. Research Design

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. HOME-BASED SLEEP APNEA DEVICES MARKET, BY TYPE OF DEVICE

  • 5.1. Introduction
  • 5.2. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
  • 5.3. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
  • 5.4. BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP) DEVICES
  • 5.5. ORAL APPLIANCES
  • 5.6. ADAPTIVE SERVO-VENTILATION (ASV) DEVICES
  • 5.7. OXYGEN DEVICES
  • 5.8. OTHERS

6. HOME-BASED SLEEP APNEA DEVICES MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. MANUAL
  • 6.3. AUTOMATIC

7. HOME-BASED SLEEP APNEA DEVICES MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. HOSPITALS AND SLEEP CLINICS
  • 7.3. HOME CARE SETTINGS
  • 7.4. SLEEP CENTERS
  • 7.5. OTHERS
  • 7.6. HOME-BASED SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY
  • 7.7. Introduction
  • 7.8. North America
    • 7.8.1. United States
    • 7.8.2. Canada
    • 7.8.3. Mexico
  • 7.9. South America
    • 7.9.1. Brazil
    • 7.9.2. Argentina
    • 7.9.3. Others
  • 7.10. Europe
    • 7.10.1. United Kingdom
    • 7.10.2. Germany
    • 7.10.3. France
    • 7.10.4. Italy
    • 7.10.5. Spain
    • 7.10.6. Others
  • 7.11. Middle East and Africa
    • 7.11.1. Saudi Arabia
    • 7.11.2. UAE
    • 7.11.3. Others
  • 7.12. Asia Pacific
    • 7.12.1. Japan
    • 7.12.2. China
    • 7.12.3. India
    • 7.12.4. South Korea
    • 7.12.5. Indonesia
    • 7.12.6. Taiwan
    • 7.12.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

  • 9.1. RESMED INC.
  • 9.2. KONINKLIJKE PHILIPS N.V.
  • 9.3. FISHER & PAYKEL HEALTHCARE LIMITED
  • 9.4. INVACARE CORPORATION
  • 9.5. DRIVE DEVILBISS HEALTHCARE
  • 9.6. BMC MEDICAL CO., LTD.
  • 9.7. COMPUMEDICS LIMITED
  • 9.8. NATUS MEDICAL INCORPORATED
  • 9.9. NIHON KOHDEN CORPORATION
  • 9.10. APEX MEDICAL CORP.